![SPI Pharma Corp Ad](https://www.pharmacompass.com/image/flap/spi-pharma-corp-ad-w36-desktop-headergif-63893.gif)
![SPI Pharma Corp Ad](https://www.pharmacompass.com/image/flap/spi-pharma-corp-ad-w36-mobile-headergif-78265.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
EU WC
Listed Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
0
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213244
https://www.prnewswire.com/news-releases/endo-launches-prevduo-neostigmine-methylsulfate-and-glycopyrrolate-injection-the-first-and-only-fda-approved-neostigmineglycopyrrolate-combination-pre-filled-syringe-301847772.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208230
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-24-2022-1661335123.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216206
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216291
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-8-2022-1654674832.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-2-2022-1643778781.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210652
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212968
https://www.pharmacompass.com/pdf/news/KRS-Global-Biotechnology-Issues-Voluntary-Nationwide-Recall-of-All-Human-and-Animal-Sterile-Drug-Products-1568424609.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-14-2019-1565765849.pdf
https://www.pharmacompass.com/pdf/news/Premier-Pharmacy-Labs-Issues-Voluntary-Nationwide-Recall-of-all-Unexpired-Sterile-Drug-Product-Lots-Due-to-Lack-of-Sterility-Assurance-1560923636.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212512
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210989
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209135
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-11-2018-1531283050.pdf
https://www.pharmacompass.com/pdf/news/fagron-sterile-services-issues-voluntary-recall-of-neostigmine-methylsulfate-1530843701.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210051
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209182
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-2-2018-1525237297.pdf
https://www.pharmacompass.com/pdf/news/premier-pharmacy-labs-issues-voluntary-nationwide-recall-of-specific-sterile-injectable-products-lots-1523508373.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-28-2018-1519803579.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-27-2017-1514352313.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209933
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-16-2017-1502850779.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208405
http://www.forbes.com/sites/brucejapsen/2016/10/12/these-10-drugs-are-busting-hospital-budgets/#4ae9da803d29
http://blogs.fda.gov/fdavoice/index.php/2015/04/reducing-the-number-of-unapproved-drugs-while-working-to-prevent-drug-shortages-a-job-that-calls-for-strong-collaboration-in-fda/
http://www.biospace.com/News/fresenius-kabi-ag-receives-fda-approval-for/361503/source=MoreNews